Close
  Indian J Med Microbiol
 

Figure 1: Levels of serum MUC3A, CA19-9 and CEA in patients with EHCC and patients without EHCC. EHCC: extrahepatic cholangiocarcinoma (n = 35) Compared with patients with pancreatic cancer (n = 30),##P < 0.01; Compared with patients with gallbladder carcinoma (n = 35), **P < 0.01; Compared with patients with benign biliary disease (n = 78),&&P < 0.01

Figure 1: Levels of serum MUC3A, CA19-9 and CEA in patients with EHCC and patients without EHCC. EHCC: extrahepatic cholangiocarcinoma (<i>n</i> = 35) Compared with patients with pancreatic cancer (<i>n</i> = 30),<sup>##</sup><i>P</i> < 0.01; Compared with patients with gallbladder carcinoma (<i>n</i> = 35), **<i>P</i> < 0.01; Compared with patients with benign biliary disease (<i>n</i> = 78),<sup>&&</sup><i>P</i> < 0.01